Champions Oncology(DE:2I3)
€4.18-0.02 (-0.48%)
DE:2I3
Champions Oncology earnings date
€4.18
At close:-0.02 (-0.48%)
Champions Oncology (2I3) Q4 2023 Earnings Report
1 Followers
DE:2I3 Q4 2023 EPS Results
- Actual EPS
- -EUR 0.15
- Consensus EPS
- -EUR 0.07
- Beat/Miss
- Missed by -EUR 0.08
- One Year Ago EPS
- -EUR 0.02
DE:2I3 Q4 2023 Revenue Results
- Actual Revenue
- EUR 11.82M
- Expected Revenue
- EUR 11.61M
- Beat/Miss
- Beat by +EUR 207.90K
- YoY Revenue Growth
- +1.51%
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 07/24/2023
- Time
- After Close
- Conference Call
- Monday, July 24, 2023
DE:2I3 Upcoming Earnings
Champions Oncology's next earnings date is estimated for December 15, 2026, based on past reporting schedules.
Q4 2023 Earnings Call Audio
DE:2I3 Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:2I3 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Dec 15, 2026 | 2027 (Q2) | ―- | 0.05 | ― | ― |
| Sep 10, 2026 | 2027 (Q1) | ―0.05 | 0.02 | 150.00% (+0.03) | |
| Jul 27, 2026 | 2026 (Q4) | ―0.01 | -0.06 | 114.29% (+0.07) | |
| Mar 12, 2026 | 2026 (Q3) | 0.08-0.02 | 0.33 | -105.56% (-0.34) | |
| Dec 15, 2025 | 2026 (Q2) | 0.000.05 | 0.05 | 20.00% (+0.01) | |
| Sep 15, 2025 | 2026 (Q1) | -0.010.02 | 0.1 | -81.82% (-0.08) | |
| Jul 23, 2025 | 2025 (Q4) | -0.18-0.06 | 0.01 | -800.00% (-0.07) | |
| Mar 11, 2025 | 2025 (Q3) | -0.010.33 | -0.14 | 325.00% (+0.47) | |
| Dec 11, 2024 | 2025 (Q2) | 0.010.05 | -0.14 | 133.33% (+0.18) | |
| Sep 11, 2024 | 2025 (Q1) | -0.030.10 | -0.14 | 168.75% (+0.24) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
